Conexo Ventures, a venture capital firm, led a $25m round in Savana, a medical company developing innovative Artificial Intelligence technologies, with participation from Knuru Capital, Aldea Ventures, Seaya Ventures, GED Capital and Cathay Innovation. “After 7 years, our vision of reinventing the way clinical research is done has become a reality; we have created the concept and processes to generate evidence through AI applied to medical records. Now it’s time to bring our capabilities into the R&D space, while expanding our services across the geographies in which we operate," Jorge Tello, Savana CEO and Co-Founder.